Primary squamous cell carcinoma of the thyroid treated with concurrent chemoradiation and palliative immunotherapy: a case report
Abstract Background Primary squamous cell carcinoma of the thyroid is a very rare malignancy with aggressive growth and poor prognosis. There is currently no consensus for treatment modality, however, most patients with primary squamous cell carcinoma of the thyroid are treated with surgery and adju...
Main Authors: | Meng-Lun Hsieh, Brian M. Besch, Jo Elle G. Peterson, Christina Henson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13256-022-03596-0 |
Similar Items
-
PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma
by: Alexander Yakobson, et al.
Published: (2023-08-01) -
Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
by: Piero Giuseppe Meliante, et al.
Published: (2023-02-01) -
Immunotherapy in head and neck squamous cell carcinoma: An updated review
by: K. Parmar, et al.
Published: (2022-01-01) -
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
by: Åse Bratland, et al.
Published: (2023-11-01) -
Treatment Response of Gingival Squamous-Cell Carcinoma to Palliative Intent Immunotherapy
by: Natalia Trehan, et al.
Published: (2023-12-01)